SEARCH

SEARCH BY CITATION

References

  • Arnold J, Alving AS, Hockwald RS et al. (1955) The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama,P.F-6 strain). Journal of Laboratory and Clinical Medicine 46, 391396.
  • Basco LK & Ringwald P (2000) Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria. American Journal of Tropical Medicine & Hygiene 63, 215221.
  • Binh TQ, Ilett KF, Batty KT et al. (2001) Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. British Journal of Clinical Pharmacology 51, 541546.
  • Bustos DG, Canfield CJ, Editha CM & Hutchinson DB (1999) Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippine. Journal of Infectious Diseases 179, 15871590.
  • Chen L (1991) Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine. Chinese Medical Journal 104, 161163.
  • Chen L, Qu FY & Zhou YC (1982) Field observations on the antimalarial piperaquine. Chinese Medical Journal 95, 281286.
  • Chen L, Qian Y & Li Z (1986) Effects of piperaquine on fine structure of erythrocytic stages of Plasmodium berghei ANKA strain. Acta Pharmacologica Sinica 7, 351353.
  • Deloron P, Le Bras J, Ramanamirija JA & Coulanges P (1985) Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Annals of Tropical Medicine & Parasitology 79, 357365.
  • Denis MB, Davis TM, Hewitt S et al. (2002) Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clinical Infectious Diseases 35, 14691476.
  • Ding G-S (1988) Recent studies on antimalarials in China: a review of literature since 1980. International Journal of Experimental and Clinical Chemotherapy 1, 922.
  • Giao PT & de Vries PJ (2001b) Pharmacokinetic interactions of antimalarial agents. Clinical Pharmacokinetics 40, 343373.
  • Giao PT, Binh TQ, Kager PA et al. (2001a) Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? American Journal of Tropical Medicine and Hygiene 65, 690695.
  • Hudson AT, Dickins M, Ginger CD et al. (1991) 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs under Experimental and Clinical Research 17, 427435.
  • Hung TY, Davis TME & Ilett KF (2003) Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detection. Journal of Chromatography B 791, 93101.
  • Iyer JK, Milhous WK, Cortese JF, Kublin JG & Plowe CV (2001) Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 358, 10661067.
  • Lafaix C, Ray M, Mar ID & Nouhouayi A (1967) Essai de traitement curatif du paludisme pour un nouvel antipaludique de synthese, le 16–126 RP. Bulletin de Societe Medicine d'Afrique Noire, Langue Francais 12, 546551.
  • Le NH, de Vries PJ, Le TD et al. (1997) Single dose artemisinin-mefloquine versus mefloquine alone for uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 191194.
  • Le NH, Na-Bangchang K, Le TD, Thrinh KA & Karbwang J (1999) Phamacokinetics of a single oral dose of dihydroartemisinin in Vietnamese healthy volunteers. Southeast Asian Journal of Tropical Medicine and Public Health 30, 1116.
  • Li GQ, Wang XH, Guo XB et al. (1999) Dose findings of dihydroartemisinin in treatment of falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 30, 1719.
  • Looareesuwan S, Chulay JD, Canfield CJ & Hutchinson DB (1999a) Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. American Journal of Tropical Medicine and Hygiene 60, 533541.
  • Looareesuwan S, Wilairatana P, Chalermarut K et al. (1999b) Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene 60, 526532.
  • McIntosh HM & Olliaro P (2000) Artemisinin derivatives for treating uncomplicated malaria (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Update Software, Oxford.
  • Na-Bangchang K, Tippanangkosol P, Ubalee R et al. (1999) Comparative clinical trial of four regimens of dihydroartemisinin-mefloquine in multidrug-resistant falciparum malaria. Tropical Medicine and International Health 4, 602610.
  • Newton PN, van Vugt M, Teja-Isavadharm P et al. (2002) Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria. Antimicrobial Agents and Chemotherapy 46, 11251127.
  • Nontprasert A, Pukrittayakamee S, Prakongpan S et al. (2002) Assessment of the neurotoxicity of oral dihydroartemisinin in mice. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 99101.
  • Slater AF (1993) Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacology and Therapeutics 57, 203235.
  • Srivastava IK & Vaidya AB (1999) A mechanism for the synergistic antimalaria action of atovaquone and Proguanil. Antimicrobial Agents and Chemotherapy 43, 13341339.
  • Thompson PE & Werbel LM (1972) Pyrimidines: Pyrimethamine Type: In Antimalarial Agents. Academic Press, New York and London, pp. 227229.
  • Tien NT, Uyen TT, Huong DX & Nhan DH (2002) Efficacy of CV8 for treatment of drug-resistant falciparum malaria. Journal of Malaria and Parasite Diseases Control, 3740.
  • Tip NQ, Trung TN, Tan TV & Phuc NT (2001) A field trial for efficacy of CV8 in treatment of uncomplicated falciparum malaria. Journal of Malaria and Parasite Diseases Control, 4551.
  • Vennerstrom JL, Ellis WY, Ager AL, Jr et al. (1992) Bisquinolines. 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria. Journal of Medicinal Chemistry 35, 21292134.
  • de Vries PJ & Dien TK (1996) Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 52, 818836.
  • de Vries PJ, Bich NN, Van Thien H et al. (2000) Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics. Antimicrobial Agents and Chemotherapy 44, 13021308.
  • van Vugt M, Leonardi E, Phaipun L et al. (2002) Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. Clinical Infectious Diseases 35, 14981504.
  • Wang W, Yang W & Micha ST (2001) Efficacy of dihydroartemisinin-mefloquine on acute uncomplicated falciparum malaria. Chinese Medical Journal 114, 612613.
  • White NJ (1999) Antimalarial drug resistance and combination chemotherapy. Philophical Transactions of the Royal Society of London B 354, 739749.
  • Wilairatna P, Krudsood S, Silachamroon U et al. (2000) Clinical trial of sequential treatments of moderately severe and severe malaria with dihydroartemisinin suppository followed by mefloquine in Thailand. American Journal of Tropical Medicine and Hygiene 63, 290294.
  • World Health Organization (2002) Report Meeting on Antimalarial Drug Development, Shanghai, China, 16–17 November 2001. RS/2001/GE/33(CHN). World Health Organization, Regional Office for the Western Pacific, Manila, Philippines.
  • Youel DB, Strickland GT, Binh BA, Clarkson R & Blackwell RQ (1971) Low incidence of erythrocyte G-6-P D deficiency in Vietnamese and Montagnards of South Vietnam. Vox Sanguinis 20, 555558.
  • Zhu DQ, Dai ZR, Li JC & Jiang ZK (1982) Studies on piperaquine as long-acting antimalarial drug against Plasmodium berghei in mice. Yao Hsueh Hsueh Pao – Acta Pharmaceutica Sinica 17, 894898.